Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

Breast Cancer Research and Treatment

Volumn 99, Issue 1, 2006, Pages 9-17

  Park, Sarah ^a,c   Shimizu, Chikako ^a   Shimoyama, Tatsu ^a   Takeda, Masayuki ^a   Ando, Masashi ^a   Kohno, Tsutomu ^a   Katsumata, Noriyuki ^a   Kang, Yoon Koo ^c   Nishio, Kazuto ^a,b   Fujiwara, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

ATP binding cassette (ABC) transporters; Breast cancer; Class prediction; Neoadjuvant chemotherapy; Oligonucleotide microarray

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ADENOSINE TRIPHOSPHATE BINDING CASSETTE B3; ADENOSINE TRIPHOSPHATE BINDING CASSETTE B6; ADENOSINE TRIPHOSPHATE BINDING CASSETTE C11; ADENOSINE TRIPHOSPHATE BINDING CASSETTE C13; ADENOSINE TRIPHOSPHATE BINDING CASSETTE C5; ADENOSINE TRIPHOSPHATE BINDING CASSETTE C7; ADENOSINE TRIPHOSPHATE BINDING CASSETTE F2; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; PROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ACCURACY; ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA MICROARRAY; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TREATMENT OUTCOME;

EID: 33746742363     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9175-2     Document Type: Article

References (33)

1. Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM: Human multidrug-resistant cell lines: increased mdrl expression can precede gene amplification. Science 232: 643-645, 1986
2. Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538-4542, 1986
3. Rosenberg MF, Mao Q, Holzenburg A, Ford RC, Deeley RG, Cole SP: The structure of the multidrug resistance protein 1 (MRP1/ABCC1). Crystallization and single-particle analysis. J Biol Chem 276: 16,076-16,082, 2001
4. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95: 15,665-15,670, 1998
5. Mechetner E, Kyshtoobayeva A, Zonis S, Kim H, Stroup R, Garcia R, Parker RJ, Fruehauf JP: Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin Cancer Res 4: 389-398, 1998
6. Candeil L, Gourdier I, Peyron D, Vezzio N, Copois V, Bibeau F, Orsetti B, Scheffer GL, Ychou M, Khan QA, Pommier Y, Pau B, Martineau P, Del Rio M: ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer 109: 848-854, 2004
7. Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS: Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 81: 696-701, 1989
8. Nakamura Y, Oka M, Soda H, Shiozawa K, Yoshikawa M, Itoh A, Ikegami Y, Tsurutani J, Nakatomi K, Kitazaki T, Doi S, Yoshida H, Kohno S: Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. Cancer Res 65: 1541-1546, 2005
9. Gillet JP, Efferth T, Steinbach D, Hamels J, de Longueville F, Bertholet V, Remacle J: Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res 64: 8987-8993, 2004
10. Szakacs G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN, Gottesman MM: Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6: 129-137, 2004
11. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr: 96-102, 2001
12. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
13. Radmacher MD, McShane LM, Simon R: A paradigm for class prediction using gene expression profiles. J Comput Biol 9: 505-511, 2002
14. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98: 15,149-15,154, 2001
15. Simon R, Radmacher MD, Dobbin K, McShane LM: Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95: 14-18, 2003
16. Ambroise C, McLachlan GJ: Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci USA 99: 6562-6566, 2002
17. Pratt S, Shepard RL, Kandasamy RA, Johnston PA, Perry W, III, Dantzig AH: The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther 4: 855-863, 2005
18. Momburg F, Hammerling GJ: Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv Immunol 68: 191-256, 1998
19. Singal DP, Ye M, Ni J, Snider DP: Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines. Immunol Lett 50: 149-154, 1996
20. Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B: Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Clin Cancer Res 11: 2552-2560, 2005
21. Cresswell AC, Sisley K, Laws D, Parsons MA, Rennie IG, Murray AK: Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease. Melanoma Res 11: 275-281, 2001
22. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Storkel S, Seliger B: MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer 109: 265-273, 2004
23. Allikmets R, Gerrard B, Hutchinson A, Dean M: Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet 5: 1649-1655, 1996
24. Wielinga P, Hooijberg JH, Gunnarsdottir S, Kathmann I, Reid G, Zelcer N, van der Born K, de Haas M, van der Heijden I, Kaspers G, Wijnholds J, Jansen G, Peters G, Borst P: The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates. Cancer Res 65: 4425-4430, 2005
25. Hu XF, Slater A, Rischin D, Kantharidis P, Parkin JD, Zalcberg J: Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cellline. Br J Cancer 79: 831-837, 1999
26. Mealey KL, Barhoumi R, Burghardt RC, Safe S, Kochevar DT: Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob Agents Chemother 46: 755-761, 2002
27. Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R: Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 23: 1161-1168, 2005
28. Schmitz G, Langmann T: Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol 12: 129-140, 2001
29. Schmitz G, Kaminski WE, Porsch-Ozcurumez M, Klucken J, Orso E, Bodzioch M, Buchler C, Drobnik W: ATP-binding cassetle transporter A1 (ABCA1) in macrophages: a dual function in inflammation and lipid metabolism?. Pathobiology 67: 236-240, 1999
30. Yabuuchi H, Takayanagi S, Yoshinaga K, Taniguchi N, Aburalani H, Ishikawa T: ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem Biophys Res Commun 299: 410-417, 2002
31. Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD: MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonyl-methoxyetliyl)adenine. J Biol Chem 278: 29,509-29,514, 2003
32. Mitsuhashi N, Miki T, Senbongi H, Yokoi N, Yano H, Miyazaki M, Nakajima N, Iwanaga T, Yokoyama Y, Shibata T, Seino S: MTABC3, a novel mitochondrial ATP-binding cassette protein involved in iron homeostasis. J Biol Chem 275: 17,536-17,540, 2000
33. Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I, Tsuruo T, Inazawa J: Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 64: 1403-1410, 2004